Ahmed Mahiuddin
Sr. VP and CSO at Y-mAbs Therapeutics, Inc.
- Sold, on record
- $4.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 26, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.Sr. VP and CSO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedMay 12, 2020 2020
Sold 20,000 shares at $39.19 ($784k)
Ahmed Mahiuddin, Sr. VP and CSO
Sold 7.7% of holdings ($10.2M position)240,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedMay 13, 2020 +1 day
Sold 10,508 shares at $37.64 ($396k)
Ahmed Mahiuddin, Sr. VP & Chief Scientific Off
Sold 4.4% of holdings ($9M position)229,492 shares leftFiling
- 3 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedMay 19, 2020 +6 days
Sold 29,492 shares at $39.41 ($1.2M)
Ahmed Mahiuddin, Sr. VP and CSO
Sold 12.9% of holdings ($9M position)200,000 shares leftFiling
- 4 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualMay 26, 2020 +7 days
Sold 50,000 shares at $39.38 ($2M)
Ahmed Mahiuddin, Sr. VP and CSO
Sold 25% of holdings ($7.9M position)150,000 shares left2.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2020 | May 27, 2020 | Y-mAbs Therapeutics, Inc. | Sr. VP and CSO | Form 4 sale | 50,000 | $2M | 25.0% | Unusual | SEC |
| May 19, 2020 | May 20, 2020 | Y-mAbs Therapeutics, Inc. | Sr. VP and CSO | Form 4 sale | 29,492 | $1.2M | 12.9% | Plan not stated | SEC |
| May 13, 2020 | May 15, 2020 | Y-mAbs Therapeutics, Inc. | Sr. VP & Chief Scientific Off | Form 4 sale | 10,508 | $396k | 4.4% | Plan not stated | SEC |
| May 12, 2020 | May 13, 2020 | Y-mAbs Therapeutics, Inc. | Sr. VP and CSO | Form 4 sale | 20,000 | $784k | 7.7% | Plan not stated | SEC |